Case Report Online Publishing Date: | ||||||||||||
Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation Nithu M Kumar1, Priyanka Sreelatha1, Shine Sadasivan2, Ankur Jain2, Anila K N1.
|
How to Cite this Article |
Pubmed Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 144-145. doi:10.5455/njppp.2018.8.0725025072017 Web Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. https://www.njppp.com/?mno=272281 [Access: March 17, 2024]. doi:10.5455/njppp.2018.8.0725025072017 AMA (American Medical Association) Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 144-145. doi:10.5455/njppp.2018.8.0725025072017 Vancouver/ICMJE Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. Natl J Physiol Pharm Pharmacol. (2018), [cited March 17, 2024]; 8(1): 144-145. doi:10.5455/njppp.2018.8.0725025072017 Harvard Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N (2018) Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. Natl J Physiol Pharm Pharmacol, 8 (1), 144-145. doi:10.5455/njppp.2018.8.0725025072017 Turabian Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. 2018. Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 144-145. doi:10.5455/njppp.2018.8.0725025072017 Chicago Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. "Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 144-145. doi:10.5455/njppp.2018.8.0725025072017 MLA (The Modern Language Association) Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N. "Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation." National Journal of Physiology, Pharmacy and Pharmacology 8.1 (2018), 144-145. Print. doi:10.5455/njppp.2018.8.0725025072017 APA (American Psychological Association) Style Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Ankur Jain, Anila K N (2018) Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 144-145. doi:10.5455/njppp.2018.8.0725025072017 |